| Particulars |
| Company Name
| Remus Pharmaceuticals Ltd
| Year End
| 202403
|
| Full Year |
| Equity (र)Cr. |
5.89 |
B.V.Rs |
139.30 |
| Sales (र)Cr. |
63.50 |
NP Rs Cr. |
16.80 |
| NP Var% |
98.00 |
Div% |
40.00 |
| CPS (र) |
30.00 |
EPS Rs |
28.50 |
| Traded Value (र)Lakhs |
0.00 |
52 Week High |
2,835.00 |
| 52 Week Low |
1,200.00 |
Price BSE |
0.00 |
| Price NSE |
2,116.00 |
Market Capital(Rs Cr.) |
1,246.51 |
| P/C Ratio |
70.40 |
P/E Ratio |
74.20 |
| Price Vs.BV |
15.19 |
|
| Latest Quarter |
| Year End |
0 |
Sales Rs Cr. |
0.00 |
| NP (र)Cr. |
0.00 |
NP Var % |
0.00 |
| Trailing Twelve Months |
| Year End |
202403 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var% |
97.64 |
EPS |
28.52 |
| PE |
74.18 |
|
|